# Cencora, Inc. (COR) — Financial Analysis and SEC Results

> Official primary source: SEC EDGAR (CIK: 1140859). Listed on NYSE.
> Sector: Salud · Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries
> Canonical URL: https://cifraresearch.com/en/empresa/COR

## Business Profile

Profile and analysis of Cencora, Inc. in the health care sector: 10-Q and 10-K results, quote and AI analysis of sales, free cash flow and capital allocation.

## Executive Financial Summary

In its most recent fiscal year (2025), Cencora, Inc. reported sales of 321.333 M$, net income of 1554 M$ and free cash flow (FCF) of 3207 M$ (1% FCF margin) (diluted earnings per share of 7,96 $).

## Annual Financial Results (Recent Fiscal Years)

| Fiscal Year | Revenue | Operating Income | Net Income | Free Cash Flow (FCF) | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | 321.333 M$ | 2629 M$ | 1554 M$ | 3207 M$ | 7,96 $ |
| 2024 | 293.959 M$ | 2175 M$ | 1509 M$ | 2998 M$ | 7,53 $ |
| 2023 | 262.173 M$ | 2341 M$ | 1745 M$ | 3453 M$ | 8,53 $ |
| 2022 | 238.587 M$ | 2366 M$ | 1699 M$ | 2207 M$ | 8,04 $ |
| 2021 | 213.989 M$ | 2354 M$ | 1540 M$ | 2228 M$ | 7,39 $ |

## 10-Q and 10-K Filings Submitted to the SEC

- [10-Q (Q2 2026)](https://www.sec.gov/Archives/edgar/data/1140859/000114085926000034/cor-20260630.htm) — Filed on 2026-08-05
- [10-Q (Q1 2026)](https://www.sec.gov/Archives/edgar/data/1140859/000114085926000020/cor-20260331.htm) — Filed on 2026-05-06
- [10-Q (Q3 2025)](https://www.sec.gov/Archives/edgar/data/1140859/000114085926000006/cor-20251231.htm) — Filed on 2026-02-04
- [10-K (FY 2025)](https://www.sec.gov/Archives/edgar/data/1140859/000114085925000131/cor-20250930.htm) — Filed on 2025-11-25
- [10-Q (Q2 2025)](https://www.sec.gov/Archives/edgar/data/1140859/000114085925000122/cor-20250630.htm) — Filed on 2025-08-06
- [10-Q (Q1 2025)](https://www.sec.gov/Archives/edgar/data/1140859/000114085925000083/cor-20250331.htm) — Filed on 2025-05-07
- [10-Q (Q3 2024)](https://www.sec.gov/Archives/edgar/data/1140859/000114085925000034/cor-20241231.htm) — Filed on 2025-02-05
- [10-K (FY 2024)](https://www.sec.gov/Archives/edgar/data/1140859/000114085924000177/cor-20240930.htm) — Filed on 2024-11-26

## Reports Analyzed with AI on Cifra

- [Report 10-K 2025 ANNUAL results — COR](https://cifraresearch.com/informe/COR/2025-10K) ([Markdown](https://cifraresearch.com/informe/COR/2025-10K.md))
- [Report 10-Q 2026 Q3 results — COR](https://cifraresearch.com/informe/COR/2026-Q3) ([Markdown](https://cifraresearch.com/informe/COR/2026-Q3.md))

## Frequently Asked Questions

### What sector and industry does Cencora, Inc. operate in?
Cencora, Inc. (COR) is listed on NYSE and operates in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry (consumer defensive sector in SEC EDGAR).

### Where can I consult official filings for COR?
In the official SEC EDGAR system under CIK 1140859 (https://www.sec.gov/edgar) or on Cifra's interactive company page (https://cifraresearch.com/en/empresa/COR).

## Citation and Attribution

Data extracted from SEC EDGAR. Analysis structured by Cifra (https://cifraresearch.com). For informational purposes only.